Correlation of CA19-9 blood marker and ability to cure pancreatic cancer with surgery
Not Applicable
- Conditions
- Health Condition 1: C259- Malignant neoplasm of pancreas, unspecified
- Registration Number
- CTRI/2024/07/071305
- Lead Sponsor
- Dr Shrey Khanna
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Phase 1 -All patients diagnosed with pancreatic cancer above 18 years of age
Phase 2 -All Patients consenting to the study who are-
Patients newly diagnosed with pancreatic tumour based on CT/MRI Findings or Biopsy
Patients who are known case of pancreatic tumour presenting to the hospital for further management
Exclusion Criteria
Patients under 18 years of age
Neuroendocrine tumours of the pancreas
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method cutoff value of CA19-9 for resectability of pancreatic tumours.Timepoint: 2 years
- Secondary Outcome Measures
Name Time Method sensitivity and specificity of CA19-9 levels with resectability of pancreatic tumours.Timepoint: 2 years